Navigation Links
Poorly Controlled Asthma Can Boost Chances of Pregnancy Complications
Date:8/11/2011

THURSDAY, Aug. 11 (HealthDay News) -- Pregnant women with poorly controlled asthma are at increased risk for pregnancy complications and for having a low-birth weight or premature baby, a new study warns.

Researchers reviewed data from 1975 to 2009 on more than 1 million pregnant women. Pregnant women with poorly controlled asthma were 50 percent more likely to develop preeclampsia (high blood pressure during pregnancy) and 25 percent more likely to have a premature baby.

Infants born to mothers with asthma weighed an average of 0.2 lbs. less at birth than those born to mothers without asthma.

The study was published in the British Journal of Obstetrics and Gynecology.

"The findings are significant and call for women with asthma to be more closely monitored during pregnancy," study leader Dr. Christina Chambers, a professor of pediatrics at the University of California San Diego and program director of the non-profit California Teratogen Information Service (CTIS) Pregnancy Health Information Line, said in a CTIS news release.

"It would be advisable for women on regular medications for asthma or having frequent symptoms to be monitored at least monthly during the course of their pregnancies," she suggested.

More information

The American Academy of Asthma, Allergy & Immunology provides an overview of asthma, allergies and pregnancy.

-- Robert Preidt

SOURCE: California Teratogen Information Service, news release, Aug. 9, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. AGH Study Shows High Rates of Poorly Controlled Asthma Among Inner-City Pittsburgh Children
2. Long-acting beta-agonists most effective step-up therapy for children with poorly controlled asthma
3. Poorly understood cell plays role in immunity against the flu
4. Older people in assisted-living facilities sleep poorly
5. Poorly presented risk statistics could misinform health decisions
6. HbA1C test for glucose monitoring poorly predictive in dialysis patients
7. Women, elderly, minorities poorly represented in lung cancer drug trial data submitted to US FDA
8. Special Needs Kids Bullied More, Fare Poorly at School
9. Poorly controlled asthma costly
10. Almac Launches New STEMS System to Transform Temperature Controlled Shipment Monitoring in Clinical Trials
11. Lacosamide validated as promising therapy for uncontrolled partial-onset seizures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... Raton, FL (PRWEB) , ... January 21, 2017 , ... ... Germany, announced it is bringing its product to the United States as part of ... over the last 25 years, Alcovit aims to reduce the productions of nasty toxins ...
(Date:1/21/2017)... ... January 21, 2017 , ... ... Relations, Dianne Travis-Teague, the electrifying line-up of events for its annual meeting “Coming ... friends, and community. “Coming Home 2017” will be held on Friday January ...
(Date:1/21/2017)... Austin, Texas (PRWEB) , ... January 21, 2017 ... ... surgeries performed by Austin, Texas Periodontist Dr. Dan Holtzclaw in media for its ... features two surgeries performed by Dr. Holtzclaw in which he utilizes creos™ ...
(Date:1/20/2017)... ... 20, 2017 , ... Source Vitál Apothecary, a skin and body care company ... the company had a successful visit to the 2017 ECRM Diet, Vitamin & Sports ... work in the nutritional, sports and health industries a chance to meet in private ...
(Date:1/20/2017)... ... January 20, 2017 , ... ... to enhance people’s everyday lives, recently attended the January ECRM Trade Show in ... Science is known for its large range of supplements that keep the body ...
Breaking Medicine News(10 mins):
(Date:1/20/2017)... , Jan 20, 2017 Research ... Testing Market By Type ([CBC, HGB/HCT, BMP, BUN Creatinine, Electrolyte Testing, ... By End-use, And Segment Forecasts, 2013 - 2024" report to ... ... 198.5 billion by 2024 Introduction of innovative solutions on ...
(Date:1/20/2017)... Research and Markets has announced the addition of the ... to their offering. ... This research service on the global pharmaceutical stability testing market ... of the key participants in the market. The ... 2020. The market is expected to grow at a CAGR of ...
(Date:1/20/2017)... Avillion LLP, a co-developer and financier of late-stage pharmaceutical product ... as Chief Medical Officer. Dr Weinberg will be based in ... ... than 17 years as a pharmaceutical and biotech executive with experience ... course of his career, he has interfaced with the US Food ...
Breaking Medicine Technology: